This inventor holds 3 USPTO granted patents. Top assignees: Applied Bio Technology, New England Deaconess Hospital Corporation, New England Deacons Hospital Corp.. Active years: 1993-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 6 
2 out of 53 
1 out of 1 Years Active: 1993-1994
Title: The Innovative Contributions of Sibusisiwe M Maswoswe
Introduction: Sibusisiwe M Maswoswe is an accomplished inventor based in Ashland, MA, known for his groundbreaking work in the field of biotechnology. With a total of three patents to his name, Maswoswe has made significant strides in the development of proteins that specifically target cancer biomarkers, paving the way for advancements in cancer detection and treatment.
Latest Patents: Maswoswe's latest patents include two key innovations centered on carcinoembryonic antigen (CEA) binding proteins. The first patent, titled "CEA-binding protein and uses thereof," discloses a protein that binds to CEA in the presence of divalent cations in vitro. This protein has a molecular weight of approximately 20 kD, is glycosylated, and contains a specific amino acid sequence listed as SEQ ID NO:4. The patent also includes disclosed methods for detecting carcinoma and treating patients with this innovative protein, as well as a kit for screening patients for carcinoma. The second patent, "Binding protein for CEA and uses thereof," describes a similar protein with a molecular weight of around 21 kD, glycosylation properties, and a different amino acid sequence (SEQ ID NO:2). This patent mirrors the applications of the first, focusing on diagnostic and therapeutic methods related to carcinoma.
Career Highlights: Throughout his career, Sibusisiwe Maswoswe has worked with notable institutions such as Applied Bio Technology and New England Deaconess Hospital Corporation. His experience in these organizations has provided him with a strong foundation in research and development, contributing to his innovative inventions.
Collaborations: Maswoswe’s work has been enhanced through collaborations with esteemed colleagues, including Joseph V Briggman and Carol A Toth. These partnerships have fostered a synergistic environment for creativity and research, enabling the pursuit of innovative solutions in cancer biotechnology.
Conclusion: Sibusisiwe M Maswoswe stands out as a pioneering inventor dedicated to improving cancer diagnostics and treatment through his patented discoveries. His contributions to the field underscore the importance of innovation in biotechnology and the potential to positively impact patient care through advanced medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile